查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1969858

2026-2034年全球近视和老花眼治疗市场规模、份额、趋势和成长分析报告

Global Myopia and Presbyopia Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 112 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计近视和老花眼治疗市场规模将从 2025 年的 275.1 亿美元成长到 2034 年的 611 亿美元，2026 年至 2034 年的复合年增长率为 9.27%。

全球近视和老花眼治疗市场正稳定成长，主要受各年龄层视力障碍患者人数不断增加的推动。萤幕使用时间的增加、电子设备的普及以及生活方式的改变，都加剧了儿童和青少年近视的盛行率。同时，全球人口老化也推动了老花眼治疗需求的成长。人口结构和生活方式因素的共同作用，持续推动全球市场的扩张。

关键成长要素包括矫正镜片、雷射手术和处方眼药水的技术进步。微创手术和个人化视力矫正方案的创新使更多患者能够选择这些治疗方案。人们对早期眼科检查和预防性眼部保健意识提升也促进了治疗方案采用率的上升。此外，新兴经济体眼科诊所和眼科医疗服务的可近性提高也为市场成长提供了支持。

展望未来，对先进隐形眼镜、智慧眼镜和新型药物疗法的持续研究有望推动市场发展。各公司正投资研发延缓儿童近视发展的长期解决方案。随着远距验光和数位化眼科筛检工具的普及，眼科服务的可近性将进一步提高。随着眼部健康日益受到重视，预计未来几年该市场将保持强劲且持续的成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球近视与老花眼治疗市场：以近视治疗类型划分

  • 市场分析、洞察与预测
  • 更正
  • 手术治疗
  • 药物

第五章：全球近视与老花眼治疗市场：依老花眼治疗方法类型划分

  • 市场分析、洞察与预测
  • 处方镜片
  • 隐形眼镜
  • 人工水晶体
  • 屈光矫正手术

第六章 全球近视与老花眼治疗市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Ziemer Ophthalmic Systems AG
    • Nidek Co. Ltd
    • Johnson & Johnson Vision
    • Essilor Ltd
    • Zeiss International
    • Alcon Vision LLC
    • Bausch & Lomb Incorporated
    • Haag-Streit UK
    • Topcon Corporation
简介目录
Product Code: VMR112110492

The Myopia and Presbyopia Treatment Market size is expected to reach USD 61.10 Billion in 2034 from USD 27.51 Billion (2025) growing at a CAGR of 9.27% during 2026-2034.

The Global Myopia and Presbyopia Treatment Market is growing steadily due to the rising number of people experiencing vision problems across all age groups. Increasing screen time, digital device usage, and changing lifestyles are contributing to a higher prevalence of myopia among children and young adults. At the same time, the aging population worldwide is driving demand for presbyopia treatments. This combination of demographic and lifestyle factors is supporting consistent market expansion globally.

Key growth drivers include technological advancements in corrective lenses, laser surgeries, and pharmaceutical eye drops. Innovations in minimally invasive procedures and customized vision correction solutions are attracting more patients. Growing awareness about early eye testing and preventive eye care is also increasing treatment adoption. In addition, better access to ophthalmology clinics and eye care services in emerging economies is supporting market growth.

In the future, the market is expected to benefit from ongoing research in advanced contact lenses, smart glasses, and novel drug therapies. Companies are investing in long-term solutions that slow myopia progression in children. The expansion of tele-optometry and digital eye screening tools will further enhance accessibility. As eye health becomes a priority, the market is projected to witness strong and sustainable growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Myopia Treatment Type

  • Corrective
  • Surgical
  • Drugs

By Presbyopia Treatment Type

  • Prescription Lenses
  • Contact Lenses
  • Intraocular Lenses
  • Refractive Surgery

COMPANIES PROFILED

  • Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Johnson Johnson Vision, Essilor Ltd, Zeiss International, Alcon Vision LLC, Bausch Lomb Incorporated, HaagStreit UK, Topcon Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY MYOPIA TREATMENT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Myopia Treatment Type
  • 4.2. Corrective Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY PRESBYOPIA TREATMENT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Presbyopia Treatment Type
  • 5.2. Prescription Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Contact Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Intraocular Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Refractive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Myopia Treatment Type
    • 6.2.2 By Presbyopia Treatment Type
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Myopia Treatment Type
    • 6.3.2 By Presbyopia Treatment Type
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Myopia Treatment Type
    • 6.4.2 By Presbyopia Treatment Type
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Myopia Treatment Type
    • 6.5.2 By Presbyopia Treatment Type
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Myopia Treatment Type
    • 6.6.2 By Presbyopia Treatment Type
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MYOPIA AND PRESBYOPIA TREATMENT INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Ziemer Ophthalmic Systems AG
    • 8.2.2 Nidek Co. Ltd
    • 8.2.3 Johnson & Johnson Vision
    • 8.2.4 Essilor Ltd
    • 8.2.5 Zeiss International
    • 8.2.6 Alcon Vision LLC
    • 8.2.7 Bausch & Lomb Incorporated
    • 8.2.8 Haag-Streit UK
    • 8.2.9 Topcon Corporation